According to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...
Read moreConsequently, paybacks from pharmaceutical manufacturers of around €1 billion will be due from pha...
Read moreThe draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...
Read moreThe DHSC is proposing to increase the statutory scheme payment percentage for 2022 from 10.9% to 14....
Read moreThe proposals are set out in the draft Statutory Health Insurance Financial Stabilisation Bill which...
Read moreAccording to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...
Read moreThe National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s Zej...
Read moreThe Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...
Read moreThe Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...
Read moreThe news comes after the health service negotiated a “significant confidential discount” to the ...
Read more